V Kretschmer, S Bade, M Weippert-Kretschmer, M A Kratzer
Index: Platelets 12(8) , 462-70, (2001)
Full Text: HTML
With the PFA-100 a sensitive and specific screening test for primary haemostasis has recently become available. An important part of the device is a capillary, providing a defined haemodynamic resistance for the perfusion of the aperture. A modified method to measure platelet function (VCP2) is presented in which the capillary essentially is replaced with an 'electronic capillary' by clamping the pressure/flow relationship.Closure time (CT) and blood volume (BV) as determined by PFA-100 and VCP2 correlated well within (r = 0.922 - 0.952) and between the two methods (r = 0.86). The test variability (CV) of CT could be significantly reduced in the VCP2 method (collagen/epi 3.9 vs. 5.9%, p<0.05; collagen/ADP 3.3 vs. 6.9%, p<0.001), thus considerably increasing test reliability and reducing test variance. In preliminary clinical studies the VCP2 system showed comparable sensitivity for vWD and slightly less sensitivity regarding ASA ingestion. The test spectrum of VCP2 could be extended to more thrombocytopenic samples (< or =20 000/microl) even in combination with low haematocrit levels (20%), thus perhaps permitting the determination of the bleeding risk in bone marrow hypoplasia. Additionally, the sensitivity and applicability can easily be adapted to the desired need only by software modifications.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
acetylsalicylsalicylic acid
CAS:530-75-6 |
C16H12O6 |
[A new possible strategy for prevention and preventive treat...
2009-03-15 [Orv. Hetil. 150(11) , 503-12, (2009)] |
Solid-state stability of aspirin in the presence of excipien...
1982-10-01 [J. Pharm. Sci. 71(10) , 1096-101, (1982)] |
Aspirin--a national survey III: Determination of impurities ...
1980-05-01 [J. Pharm. Sci. 69(5) , 550-3, (1980)] |
The quantitative determination of aspirin and its degradatio...
1995-02-01 [J. Pharm. Biomed. Anal. 13(2) , 111-9, (1995)] |
Efficacy of 1,000 mg effervescent acetylsalicylic acid and s...
2004-01-01 [Eur. Neurol. 52(1) , 50-6, (2004)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved